Tapering Benzodiazepines
Introduction to Tapering
- The Centers for Disease Control and Prevention recommends tapering opioids first before tapering diazepam due to the greater risks of benzodiazepine withdrawal relative to opioid withdrawal 1
Non-Pharmacological Interventions
- Cognitive behavioral therapy (CBT) significantly increases tapering success rates and should be offered alongside the medication taper, according to the Centers for Disease Control and Prevention 1
- Non-pharmacological approaches, such as cognitive behavioral therapy, regular exercise, sleep hygiene practices, and stress management techniques, can be used to manage withdrawal symptoms, as recommended by the MMWR Recommendations and Reports 2
Tapering Guidelines
- A standard taper of reducing the dose by 5-10% of the original dose every 1-2 weeks is recommended, with larger initial reductions for high doses (>60 mg/day) and slower reductions for lower doses (<30 mg/day), as suggested by the American Academy of Addiction Psychiatry 3
- The following tapering schedule is recommended:
| Current Daily Dose | Recommended Taper | |
|---|---|---|
| >600 mg/day | Reduce by 150 mg/day every 7 days until reaching 300 mg/day, then slow to 50-75 mg/day reductions | |
| 300-600 mg/day | Reduce by 75 mg/day every 7 days | |
| <300 mg/day | Reduce by 50 mg/day every 7 days | [4] |
- More gradual tapering (5% reduction every 2-4 weeks) may be necessary for some patients, with a lower initial diazepam equivalent dose (25-50% reduction), as suggested by the Mayo Clinic 5
Special Populations
- Elderly patients should undergo a more gradual tapering schedule (5% reduction every 2 weeks), as suggested by geriatric care guidelines 6, 7
- Patients with hepatic impairment should have their initial dose reduced by 50% and tapered more gradually, while those with renal impairment should have their initial dose reduced by 25-50% and the tapering schedule individualized, according to standard medical practice 6, 7
- Pregnant women taking benzodiazepines should be tapered under specialist supervision with a gradual reduction schedule rather than abrupt discontinuation to minimize risks to both mother and fetus, as recommended by the Centers for Disease Control and Prevention (CDC) 8
Withdrawal Symptom Management
- Common withdrawal symptoms include anxiety, irritability, insomnia, tremor, diaphoresis, agitation, hypertension, tachycardia, hyperalgesia, and myoclonus, and should be assessed before each dose reduction, as recommended by the American Academy of Addiction Psychiatry 3
- The following medications may be used to manage specific symptoms:
| Medication | Indication | |
|---|---|---|
| Clonidine | Sympathetic hyperactivity | |
| Loperamide | Gastrointestinal symptoms | |
| Trazodone | Insomnia and anxiety | |
| Hydroxyzine | Anxiety and agitation | |
| Gabapentin | Insomnia and anxiety | |
| Mirtazapine | Insomnia and anxiety | |
| NSAIDs/Acetaminophen | Pain | [9] |
- Scheduled acetaminophen (not exceeding 3000mg daily) may be considered for pain management during tapering, as recommended by 5
Patient Monitoring and Treatment
- Patients with a history of anxiety disorders, seizure disorders, or opioid use disorder may require closer monitoring and a slower tapering schedule, as recommended by the CDC and medical guidelines 2, 4, 7
- Patients concurrently using opioids should be prescribed the lowest effective benzodiazepine dose, as implied by the need to assess for concurrent substance use [8] [10]
- Patients with opioid use disorder may benefit from transitioning to buprenorphine, as recommended by the Mayo Clinic 3
- Outpatient management is suitable for patients without a history of withdrawal seizures or delirium tremens, no significant medical or psychiatric comorbidities, adequate social support, and no concurrent serious medical conditions, with initial diazepam dosing at 5-10 mg every 6-8 hours, then tapered gradually by 10% of the original dose per week, as recommended by the American Association for the Study of Liver Diseases and the European Association for the Study of the Liver 11, 12
- Inpatient treatment is indicated for patients with significant alcohol withdrawal syndrome, history of withdrawal seizures or delirium tremens, concurrent serious medical or psychiatric illness, or failure of previous outpatient treatment, with diazepam dosing similar to outpatient management, as recommended by the American Association for the Study of Liver Diseases 11